Abstract: The present invention relates to a benzazepinone compound represented by the following formula (I): [Formula 1] wherein R represents a C1-C6 alkyl group or halogeno C1-C6 alkyl group, R2 represents a carboxyl group which may be protected, and Y represents a group represented by the formula (II): [Formula 2] wherein Z represents CH or a nitrogen atom, or a pharmaceutically acceptable salt thereof.
| # | Name | Date |
|---|---|---|
| 1 | 3825-DELNP-2010-Form-13-(31-05-2010).pdf | 2010-05-31 |
| 2 | 3825-delnp-2010-Form-3-(03-11-2010).pdf | 2010-11-03 |
| 3 | 3825-delnp-2010-Correspondence-Others-(03-11-2010).pdf | 2010-11-03 |
| 4 | abstract.jpg | 2011-08-21 |
| 5 | 3825-delnp-2010-gpa.pdf | 2011-08-21 |
| 6 | 3825-delnp-2010-form-5.pdf | 2011-08-21 |
| 7 | 3825-delnp-2010-form-3.pdf | 2011-08-21 |
| 8 | 3825-delnp-2010-form-2.pdf | 2011-08-21 |
| 9 | 3825-delnp-2010-form-13.pdf | 2011-08-21 |
| 10 | 3825-delnp-2010-form-1.pdf | 2011-08-21 |
| 11 | 3825-delnp-2010-description (complete).pdf | 2011-08-21 |
| 12 | 3825-delnp-2010-correspondence-others.pdf | 2011-08-21 |
| 13 | 3825-delnp-2010-claims.pdf | 2011-08-21 |
| 14 | 3825-delnp-2010-assignment.pdf | 2011-08-21 |
| 15 | 3825-delnp-2010-abstract.pdf | 2011-08-21 |
| 16 | 3825-delnp-2010-Form-18-(11-11-2011).pdf | 2011-11-11 |
| 17 | 3825-delnp-2010-Correspondence-others-(11-11-2011).pdf | 2011-11-11 |
| 18 | 3825-DELNP-2010-FER.pdf | 2016-12-22 |
| 19 | Form 4 [29-05-2017(online)].pdf | 2017-05-29 |
| 20 | Verified English Translation [31-05-2017(online)].pdf | 2017-05-31 |
| 21 | Form 3 [31-05-2017(online)].pdf | 2017-05-31 |
| 22 | 3825-DELNP-2010-OTHERS-020617.pdf | 2017-06-07 |
| 23 | 3825-DELNP-2010-Correspondence-020617.pdf | 2017-06-07 |
| 24 | 3825-DELNP-2010-OTHERS-020617..pdf | 2017-06-28 |
| 25 | 3825-DELNP-2010-OTHERS-020617-1.pdf | 2017-06-28 |
| 26 | 3825-DELNP-2010-AbandonedLetter.pdf | 2017-11-09 |
| 1 | search_20-12-2016.pdf |